Ocera Therapeutics Report issue

For profit Phase 2 Phase 3
Founded: Palo Alto CA United States (2005)
Status: Acquired by Mallinckrodt (2013) (2017)

Organization Overview

First Clinical Trial
2006
NCT00321412
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ocera Therapeutics | Ocera Therapeutics, Inc.